PolyU has developed a new class of antibiotic drug candidates for fighting against multi-drug resistant superbugs. The new drug candidates demonstrate much effective abilities of inhibiting bacterial growth than commonly used antibiotics, yet with no toxicity to human cells. It is believed that further studies on these compounds will contribute to a new era of antibiotic discovery.